overactive bladder
Conditions
Interventions
TENS plus mirabegron group:TENS combined with mirabegron (Astellas) 50mg, once a day was given. Two skin-adhesive electrodes were attached to the skin according to the plan of placing the negative el
fake TENS plus mirabegron group:Mirabegron (Astellas) 50mg once daily combined with sham TENS for 30 min was given. The stimulation amplitude was set to 0 using the same TENS setup, electrode position
Sponsors
The General Hospital of Chongqing Steel Company
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Female patients, aged 18-75 years, met the diagnostic criteria of OAB in the Chinese Guidelines for the diagnosis and treatment of Urological diseases, and did not take OAB drugs, drugs affecting urination, or other treatment within 2 weeks.
Exclusion criteria
Exclusion criteria: (1) routine urine and urine culture suggesting acute and chronic urinary tract infection; (2) ultrasonography and CT suggesting urinary calculi and tumors; (3) urodynamics suggesting bladder outlet obstruction; (4) neurogenic bladder; (5) severe liver and kidney dysfunction and cardiopulmonary dysfunction; (6) mental disorders and the inability to cooperate throughout the whole course of treatment; (7) allergy or contraindication to mirabegron; and (8) pacemaker installation, pregnancy or lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3 day Voiding diary; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overactive Bladder Symptom Score;Overactive Bladder Questionnaire short form;treatment satisfaction-visual analogue scale; | — |
Countries
China
Contacts
Public ContactLiang Zhao
The General Hospital of Chongqing Steel Company
Outcome results
None listed